Quinine Market 2026 expanding steadily toward $3.76 billion by 2030

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Quinine Market During 2026–2030?

The quinine market has demonstrated considerable expansion in recent years. It is anticipated to increase from $2.45 billion in 2025 to $2.68 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.2%. The historical growth of the market can be attributed to traditional reliance on cinchona bark extraction, limited availability of purified quinine, widespread use in malaria treatment, use in home remedies and tonic beverages, and adoption in oral formulations.

The quinine market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $3.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.8%. Factors contributing to this growth during the projection period include technological breakthroughs in quinine production and refinement, a surge in demand for quinine suitable for pharmaceuticals, the broadening scope of malaria prevention initiatives, the proliferation of functional drinks incorporating quinine, and heightened funding for antimalarial research and development efforts. Key trends characterizing the forecast duration encompass a growing preference for natural antimalarial substances, the expanding application of quinine in tonic water and health-focused beverages, the creation of pharmaceutical-grade quinine derivatives, heightened public understanding of malaria prevention and therapies, and a strong emphasis on meeting regulatory requirements and upholding quality benchmarks for quinine items.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24676&type=smp

What Underlying Factors Are Accelerating The Growth Of The Quinine Market?

The increasing occurrence of malaria is projected to drive the expansion of the quinine market in the future. This infectious illness results from Plasmodium parasites, spread to humans via the sting of infected female Anopheles mosquitoes. The rise in malaria cases is linked to higher global temperatures, extending the geographical reach and reproductive period of these malaria-transmitting mosquitoes. Quinine, a strong antimalarial medication, combats malaria by disrupting the parasite’s capacity to process hemoglobin within red blood cells, thereby hindering its development and existence. For example, data from April 2024 by the UK Health Security Agency, a UK-based government body, revealed 2,004 verified malaria cases in England in 2023, marking an increase from 1,369 in 2022. Consequently, the growing incidence of malaria is fueling the demand in the quinine market.

How Are The Various Segments Of The Quinine Market Categorized?

The quinine market covered in this report is segmented –

1) By Product: Quinine Sulphate, Quinine Hydrochloride, Quinine Gluconate, Quinine Bisulphate

2) By Administration: Oral Administration, Intramuscular Administration, Intravenous Administration, Other Administrations

3) By Application: Malaria Treatment, Nocturnal Leg Cramps

4) By Enduser: Hospitals, Clinics, Other Endusers

Which Major Firms Influence Developments In The Quinine Market?

Major companies operating in the quinine market are Teva Pharmaceutical Industries Ltd., Schweppes Australia Proprietary Limited, The United States Pharmacopeial Convention Inc., Chempro Pharma Private Limited, Taj Pharmaceuticals Ltd., Swiss Parenterals Private Limited, Leocorno Enterprises Private Limited, Healthy Inc., Jai Radhe Sales, Adooq Bioscience LLC, Akhil Healthcare Pvt Ltd., Van Wankum Ingredients B.V., Shreeji Pharma International, Prism Industries Private Limited, Lavina Pharmaceuticals Pvt Ltd., A. B. Enterprises, Spark Lifesciences Private Limited, Sihauli Chemicals Private Limited, Shanghai Nianxing Industrial Co. Ltd., Sakhiya Pharma Chem

Read the full quinine market report here:

https://www.thebusinessresearchcompany.com/report/quinine-global-market-report

Which Region Is Projected To Dominate The Quinine Market During The Forecast Period?

North America was the largest region in the quinine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the quinine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Quinine Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24676&type=smp

Browse Through More Reports Similar to the Global Quinine Market 2026, By The Business Research Company

Malaria Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/malaria-treatment-global-market-report

Malaria Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/malaria-vaccines-global-market-report

Chitosan Market Report 2026

https://www.thebusinessresearchcompany.com/report/chitosan-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795